FDA Inspection 1017592 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on June 9, 2017 in Van Nuys, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 9, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Van Nuys, CA (United States)